Comments
Loading...

Summit Therapeutics

SMMTNASDAQ
Logo brought to you by Benzinga Data
$19.00
0.331.77%
At close: -
$19.00
0.000.00%
After Hours: 2:59 PM EDT

Summit Therapeutics (NASDAQ:SMMT) Stock, Earnings Estimates, EPS, And Revenue

Summit Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 18
EPS Estimate
$-0.070
Quarterly Revenue Estimate
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Summit Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Summit Therapeutics (SMMT) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-10-30$-0.05$-0.0728.6 %
Jun 20242024-08-06$-0.05$-0.0616.7 %
Sep 20212021-11-15$-0.20$-0.2828.6 %

Summit Therapeutics (SMMT) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20212021-08-11$57.00K$4.45M-98.7 %

FAQ

Q

When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?

A

Summit Therapeutics (SMMT) is scheduled to report earnings on February 18, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Summit Therapeutics (NASDAQ:SMMT)?

A

The Actual EPS was $-0.05, which beat the estimate of $-0.07.

Q

What were Summit Therapeutics’s (NASDAQ:SMMT) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch